文献速递头颈外科

分化型甲状腺癌诊断与治疗后的健康相关生活质量及与手术类型的关系

Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2019-01-01

该内容分析纳入澳大利亚昆士兰州1005例近期诊断的分化型甲状腺癌患者,分析其对开放问题的回答以编码健康相关生活质量主题。77.1%患者报告生活质量问题,全甲状腺切除术(未行颈清扫)者报告生活质量问题或治疗不良反应的比值比为1.49(95%CI 1.04-2.12),高于半甲状腺切除术者。

要点

  • 1005例分化型甲状腺癌患者中775例(77.1%)报告诊断和治疗后存在健康相关生活质量问题。
  • 全甲状腺切除术(未行颈清扫)者报告生活质量问题或治疗不良反应的比值比为1.49(95%CI 1.04-2.12),高于半甲状腺切除术者。
  • 作者认为对于小而局限的分化型甲状腺癌,半甲状腺切除术可能比全甲状腺切除术带来更少治疗不良反应和更好的生活质量结局。

核心结论

  • 分化型甲状腺癌患者报告广泛的健康相关生活质量问题,全甲状腺切除术者比半甲状腺切除术者更常见。
  • 作者认为对于小而局限的分化型甲状腺癌,半甲状腺切除术可能比全甲状腺切除术带来更少治疗不良反应和更好的生活质量结局。
  • 作者认为患者和医生在决定分化型甲状腺癌诊断后的最佳治疗方式时应考虑健康相关生活质量问题。

研究设计与样本

  • 内容分析,评估澳大利亚昆士兰州主要甲状腺癌术后治疗中心和基于人群的癌症登记处收录的患者对诊断和治疗后结局与担忧的开放问题的回答。
  • 参与者年龄18至79岁,近期诊断为甲状腺癌;1416例合格患者中1005例(71.0%)参与。
  • 数据收集时间为2013年7月1日至2016年8月31日,分析时间为2018年1月11日至2018年4月9日。

主要发现

  • 分析纳入1005例分化型甲状腺癌患者,女性72.2%(n=726),平均年龄52岁(SD 14.0岁)。
  • 大多数患者为甲状腺乳头状癌(889/1003,88.6%),肿瘤小于2 cm(564/1000,56.4%),接受全甲状腺切除术(791/1005,78.7%)。
  • 775例患者(77.1%)报告诊断和治疗后存在健康相关生活质量问题。
  • 内容分析得出4个主要主题:生理(663例,66.0%)、心理(187例,18.6%)、生活方式(82例,8.2%)、无问题或不良反应(246例,24.5%)。
  • 全甲状腺切除术(未行颈清扫)者报告生活质量问题或治疗不良反应的比值比为1.49(95%CI 1.04-2.12),高于半甲状腺切除术者。

临床怎么用

  • 作者认为对于小而局限的分化型甲状腺癌,半甲状腺切除术可能比全甲状腺切除术带来更少治疗不良反应和更好的生活质量结局。
  • 作者认为患者和医生在决定分化型甲状腺癌诊断后的最佳治疗方式时应考虑健康相关生活质量问题。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Concerns around possible overdiagnosis and overtreatment of differentiated thyroid cancer (DTC) have been raised. Issues concerning health-related quality of life (HRQOL) after diagnosis and treatment of DTC are understudied in this patient group. OBJECTIVE: To better understand the range of HRQOL outcomes, including possible adverse effects of treatment, associated with diagnosis and treatment of DTC and whether these outcomes vary by type of surgery received. DESIGN, SETTING, AND PARTICIPANTS: This content analysis assessed responses to an open-ended question about outcomes and concerns after DTC diagnosis and treatment among patients ascertained from the major postsurgical thyroid cancer treatment center and the population-based Cancer Registry in Queensland, Australia. Participants were aged 18 to 79 years and recently diagnosed with throid cancer. Responses underwent analysis to identify and code emergent themes to describe HRQOL issues and adverse effects of treatment experienced. Quantitative analysis was used to explore whether surgery type was associated with HRQOL issues and/or adverse effects of treatment. Of 1416 eligible patients, 1005 (71.0%) participated. Data were collected from July 1, 2013, through August 31, 2016, and analyzed from January 11 through April 9, 2018. MAIN OUTCOMES AND MEASURES: Issues concerning HRQOL. RESULTS: The analysis included 1005 patients (72.2% female [n = 726]; mean [SD] age, 52 [14.0 years) with DTC. Most patients were diagnosed with papillary thyroid cancer (889 of 1003 [88.6%]), had tumors smaller than 2 cm in size (564 of 1000 [56.4%]), and received a total thyroidectomy (791 of 1005 [78.7%]). Overall, 775 patients (77.1%) reported HRQOL issues after diagnosis and treatment of DTC. The following 4 main themes emerged from content analysis of patient responses: physical (663 [66.0%]), psychological (187 [18.6%]), lifestyle (82 [8.2%]), and no issue or adverse effect (246 [24.5%]). Patients who had a total thyroidectomy (without neck dissection) were 1.5 times (odds ratio, 1.49; 95% CI, 1.04-2.12) more likely to report an HRQOL issue or an adverse effect of treatment compared with patients who underwent a hemithyroidectomy. CONCLUSIONS AND RELEVANCE: According to results of this study, patients diagnosed with DTC report wide-ranging HRQOL issues; these are more prevalent among patients who have total thyroidectomies rather than hemithyroidectomies. For patients with small, localized DTCs, hemithyroidectomy may offer fewer adverse effects of treatment and better HRQOL outcomes than total thyroidectomy. It appears that issues with HRQOL should be considered by patients and physicians when deciding on the best treatment approach after a diagnosis of DTC.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Nickel B, Tan T, Cvejic E, et al. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 30653212. doi:10.1001/jamaoto.2018.3870

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。